Assessments and tests during study visits may include:

Collection of personal and health data, such as age, sex, medical history, and current medications

Measurement of weight and height

Collection of a small amount of blood

Collection of a small amount of urine

Checking for any unexpected health issues or side effects after being given the investigational drug

Completing questionnaires to rate own health and effects of HS on well-being

Visual body checks for any visible health issues, listening to the heart and lungs, checking body temperature and blood pressure

Review of other medications taken since the previous study visit

Participation Criteria

You may be eligible to participate if you:

  • Are between 12 to 17 years old, inclusive
  • Have been diagnosed with hidradenitis suppurativa (HS) at least 6 months ago
  • Have moderate to severe HS
  • Have at least 5 inflammatory HS lesions
  • Have HS affecting two or more different areas of the body
  • Have tried a systemic antibiotic (pills, liquid, or IV) for HS in the past that did not work well
  • Weigh at least 30 kg (about 66 pounds)
  • Are willing to attend study visits and follow study instructions

You may not be eligible if you:

  • Have a history of inflammatory bowel disease (IBD)
  • Have active tuberculosis (TB) or untreated latent TB
  • Have had serious or ongoing infections
  • Have received certain medications for HS in the past
  • Have participated in this same study before
  • Have had recent severe depression, suicidal thoughts, or psychiatric hospitalization
  • Are currently taking medications that are not allowed by the study

The study team will go through multiple other checks to confirm if the study is the right fit for anyone interested in participating.

Why join the BE AWARE Study?

Joining a clinical research study is a very personal and individual decision, so please take time to consider if this is the right choice. Any participant can stop study participation/withdraw at any time without having to give a reason.

Deciding not to take part will not affect any medical care now or in the future. However, study participation is incredibly valuable. The main goal of the study is to learn more about how the investigational drug affects young people like you/your child who have HS.

What are the potential risks and benefits of the BE AWARE Study?

Participants may not see any personal benefit from joining the BE AWARE Study. Before entering the study, more detailed information on what side effects can happen during the study will be discussed. Participants and caregivers should talk to the study doctor about any potential side effects of concern.


It is crucial to test HS drugs in children and teenagers living with this condition because:

  • Young bodies can react differently to drugs compared to adults.
  • Knowing the right dosage for different ages or body weights is important.
  • It allows testing for safety and efficacy so treatments can be developed for all age groups.
  • It helps to understand any unique side effects in younger people.

Important Notes

Always talk with your healthcare provider before joining a research study.

This study is not a guarantee of benefit.

Not everyone who applies will qualify.

Final eligibility is determined by the study team.

Contact Info

For more information about the study or to find the nearest site:

Recruiting Study Locations (US)

Arizona

Phoenix, AZ

For questions or comments, please contact the study coordinator for this location:
Cing Vung – vcing@usdermpartners.com

California

Roseville, CA

For questions or comments, please contact the study coordinator for this location:
Sandra Bello sandraclinicaltrials@gmail.com

Sacramento, CA

For questions or comments, please contact the study coordinator for this location:
Hasina Safi – 
hasina@integrativeskinresearch.com

Florida

Miami, FL

For questions or comments, please contact the study coordinator for this location:
Patricia Di Taranto –
ped49@med.miami.edu

Kentucky

Franklin, KY
For questions or comments, please contact the study coordinator for this location:
Amy Steward –
asteward@equity-med.com

Michigan

Clarkston, MI

For questions or comments, please contact the study coordinator for this location:
Brianna Cole – bcole@docsdermgroup.com

Danielle Bartlett – dbartlett@docsdermgroup.com


Fort Gratiot, MI

For questions or comments, please contact the study coordinator for this location:
Camrynn Campbell – ccollinge@hamzavi.com

Alyson Campbell – ACampbell@hamzavi.com


Troy, MI

For questions or comments, please contact the study coordinator for this location:
Navya Kamath – nkamath@rev-research.com

New York

Brooklyn, NY
For questions or comments, please contact the study coordinator for this location: COMING SOON.

North Carolina

Chapel Hill, NC

For questions or comments, please contact the study coordinator for this location:
Michael Povelaitis –
michael_povelaitis@med.unc.edu

Ohio

Fairborn, OH
For questions or comments, please contact the study coordinator for this location:
Jessica Hong – jessica.hong@wright.edu

Texas

Arlington, TX

For questions or comments, please contact the study coordinator for this location:
Alicia Soulivong – alicias@acderm.com

Washington DC

Washington, DC

For questions or comments, please contact the study coordinator for this location:
Akosua Otoo – aotoo@childrensnational.org